Though only a few months old and still in the process of building up its infrastructure, the Gene Silencing Section of the National Cancer Institute's Center for Cancer Research is already getting things moving. First up for the organization is an invitation-only meeting of academics and industry players focused on the use of RNA interference in combating childhood cancers.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.